Blood neurofilament light chain levels are elevated in paediatric patients with multiple sclerosis and reduced under disease-modifying treatment

被引：0
|
作者：
Reinert, M. -C. [1 ]
Kropshofer, H. [2 ]
Barro, C. [3 ,4 ]
Wuerfel, J. [5 ,6 ]
Benkert, P. [3 ,4 ]
Michalak, Z. [3 ,4 ]
Brueck, W. [7 ]
Huppke, P. [1 ]
Tomic, D. [2 ]
Leppert, D. [2 ]
Kuhle, J. [3 ,4 ]
Gaertner, J. [1 ]
机构：
[1] Georg August Univ Gottingen, Univ Med Ctr Gottingen, Div Pediat Neurol, Dept Pediat & Adolescent Med, Gottingen, Germany
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ Basel, Univ Hosp Basel, Dept Med, Neurol Clin & Policlin, Basel, Switzerland
[4] Univ Basel, Univ Hosp Basel, Dept Biomed & Clin Res, Neurol Clin & Policlin, Basel, Switzerland
[5] Med Image Anal Ctr MIAC AG, Basel, Switzerland
[6] Univ Basel, Dept Biomed Engn, Basel, Switzerland
[7] Georg August Univ Gottingen, Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
基金：
新加坡国家研究基金会; 欧盟地平线“2020”;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1793
引用
收藏
页码：1023 / 1023
页数：1
相关论文
共 50 条
  • [31] Effect of disease-modifying treatment on coronavirus disease 2019 vaccination in patients with multiple sclerosis
    D'haeseleer, M.
    Van Remoortel, A.
    D'hooghe, M.
    Della Faille, L.
    Nagels, G.
    Van Schependom, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 429 - 430
  • [32] Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple Sclerosis
    Bruno, Antonio
    Annovazzi, Pietro
    Clerico, Marinella
    Cocco, Eleonora
    Conte, Antonella
    Marfia, Girolama Alessandra
    Salvetti, Marco
    Tomassini, Valentina
    Clerici, Valentina Torri
    Totaro, Rocco
    Dolcetti, Ettore
    Centonze, Diego
    CURRENT NEUROPHARMACOLOGY, 2024,
  • [33] Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
    Spessotto, Caroline
    Cavalli, Hanaie
    Eboni, Audred
    Machado, Rafael
    Mousquer, Analara
    Palazzo, Lara
    Finkelsztejn, Alessandro
    Goncalves, Marcos
    Sato, Henry
    Siquineli, Fabio
    Fragoso, Yara
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 141 - 141
  • [34] Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States
    Bonafede, Machaon M.
    Johnson, Barbara H.
    Wenten, Made
    Watson, Crystal
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1501 - 1512
  • [35] Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
    Spessotto, Caroline Vieira
    Cavalli, Hanaie
    Biondo Eboni, Audred Cristina
    Machado, Rafael Berlezi
    Mousquer, Analara Munardi
    Palazzo, Lara Both
    Finkelsztejn, Alessandro
    Magno Goncalves, Marcus Vinicius
    Sato, Henry Koiti
    Siquineli, Fable
    Fragoso, Yara Dadalti
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (08) : 617 - 620
  • [36] Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple Sclerosis
    Reinert, Marie-Christine
    Huppke, Brenda
    Hummel-Abmeier, Hannah
    Stark, Wiebke
    Gaertner, Jutta
    Huppke, Peter
    NEUROLOGY, 2023, 101 (19) : E1873 - E1883
  • [37] Renal function influences serum neurofilament light chain levels in patients with multiple sclerosis
    Gasque Rubio, R.
    Cubas Nunez, L.
    Castillo Villalba, J.
    Carratala Bosca, S.
    Alcala, C.
    Perez Miralles, F.
    Quintanilla Bordas, C.
    Laiz Marro, B.
    Casanova Estruch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 585 - 585
  • [38] Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study
    Cuello, J. P.
    Martinez Gines, M. L.
    Kuhle, J.
    Garcia Dominguez, J. M.
    Lozano Ros, A.
    Romero Delgado, F.
    Higueras, Y.
    Meldana Rivera, A.
    Goicochea Briceno, H.
    Garcia-Tizon Larroca, S.
    De Leon-Luis, J.
    Michalak, Z.
    Barro, C.
    Alvarez Lafuente, R.
    Medina Heras, S.
    Fernandez Velasco, J. I.
    Tejeda-Velarde, A.
    Dominguez-Mozo, M. I.
    Muriel, A.
    de Andres, C.
    Villar, L. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (09) : 1200 - 1204
  • [39] Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study
    Cuello, J. P.
    Martinez Gines, M. L.
    Lozano Ros, A.
    Romero Delgado, F.
    Garcia Dominguez, J. M.
    Higueras, Y.
    Meldana Rivera, A.
    Garcia Tizon, S.
    de Leon-Luis, J.
    Ortega Abad, V.
    Perez Perez, S.
    Dominguez-Mozo, M. I.
    Alvarez Lafuente, R.
    Medina Heras, S.
    Fernandez Velasco, J. I.
    Tejeda-velarde, A.
    Andres, C. de
    Goicochea Briceno, H.
    Kuhle, J.
    Michalak, Z.
    Barro, C.
    Villar Guimerans, L. M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 556 - 556
  • [40] Blood Neurofilament Light Chain Levels and Association with Brain Volume Change in Patients with Primary Progressive Multiple Sclerosis and Relapsing Multiple Sclerosis Before and During Ocrelizumab Treatment
    Jia, Xiaoming
    Herman, Ann
    Harp, Christopher
    Cross, Anne
    Fiore, Damian
    Hauser, Stephen
    Kappos, Ludwig
    Koendgen, Harold
    Kuhle, Jens
    Leppert, David
    Manfrini, Marianna
    Model, Fabian
    Oksenberg, Jorge
    Sauter, Annette
    Thanei, Gian-Andrea
    Bar-Or, Amit
    NEUROLOGY, 2020, 94 (15)
12345